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INVITED COMMENTARY
Peter K. Henke, MD, Ann Arbor, Mich
The clinical predictors of abdominal aortic aneurysm (AAA) ex-
pansion and rupture have recently been better delineated in random-
ized trials, but the dominant factor for rupture risk remains aortic
diameter. Indeed, an aortic diameter of5.5 cm is the cutoff for risk
benefit-ratio for operative repair.1 Many large AAAs do not rupture,
and it would be ideal to have additional patient-level information that
might better predict the risk of an AAA rupture. It is now clear from
recent sophisticated computed tomography imaging studies that ge-
ometry and wall stress play a significant role in local aortic wall stress.
For example, significant aortic tortuosity and asymmetric geometry
confer a greater AAA rupture risk.2
The study by Martino et al highlights a correlative measure of
aortic wall strength and thickness in humans. Specifically, compar-
ison was made of wall thickness and tensile strength between
ruptured AAA and elective AAA tissue. The authors show that
mean aortic wall thickness was greater in ruptured compared with
nonruptured tissue. Further, tensile strength of the ex vivo speci-
men was lower in ruptured aortic tissue than nonruptures (P .04,
noncorrected). Although this study is limited by its small patient
number, lack of a normal aorta control group for biomechanical
parameters and imaging, and heterogeneity of specimens, this
study is intriguing and hypothesis generating.
While it is not counterintuitive that ruptured AAA tissue speci-
mensmay have weaker tissue than intact AAAs, it is important to note
that the tissue analyzed was not from the site of rupture but the
anterior wall. Thus, patients with any given size AAA may have
intrinsically weaker walls throughout the aorta. Supportive of this, but
not necessarily intuitive, is the finding that ruptured AAAs have
thicker walls. This is consistent with greater inflammatory processes in
these aortas. The molecular pathologic remodeling process was not
evaluated in this study, but likely involves leukocyte-driven matrix
breakdown via matrix metalloproteinase activity. Complementary
studies with gene array and single nucleotide polymorphism analysis
hold further promise to elucidate these mechanisms.
The current paper adds to our understanding of end-stage
AAA pathophysiology in humans. These data require further vali-
dation in larger patient imaging studies, particularly to determine a
threshold thickness of aortic wall as a prognostic variable. In
addition to the well known risk factors of AAA growth including
size, smoking, diastolic, hypertension, and emphysema, we should
now also consider the finer points of imaging analysis.
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